Emisphere Technologies to Hold Annual Stockholders Meeting on April 20, 2007

Search Blogs that Mention this News Release

Click this link to view linked Bookmarking Services

Click this link to view linked Blogging Services

Emisphere Technologies to Hold Annual Stockholders Meeting on April 20, 2007

    TARRYTOWN, N.Y., April 18 /PRNewswire-FirstCall/ -- Emisphere
Technologies, Inc. (Nasdaq: EMIS) announced today that it will host its
Annual Stockholders Meeting on Friday, April 20, 2007 at the Westchester
Marriott Hotel, 670 White Plains Road, Tarrytown, NY. The meeting will
begin at 10:00 a.m. EDT.
    Webcast Information
    For those stockholders who are unable to attend, Emisphere will webcast
the meeting. To access the live broadcast via the Internet in listen-only
mode, or the subsequently archived recording, please go to our Company
website at http://www.emisphere.com. The webcast can also be directly accessed at
the following link:
    http://phx.corporate-ir.net/phoenix.zhtml?p=irol-
    eventDetails&c=78250&eventID=1517121
    Please visit the site at least five minutes prior to start time for
instructions.
    About Emisphere Technologies, Inc.
    Emisphere Technologies, Inc. is a biopharmaceutical company pioneering
the oral delivery of otherwise injectable drugs. Emisphere's business
strategy is to develop oral forms of injectable drugs, either alone or with
corporate partners, by applying its proprietary eligen(R) technology to
those drugs or licensing its eligen(R) technology to partners who typically
apply it directly to their marketed drugs. Emisphere's eligen(R) technology
has enabled the oral delivery of proteins, peptides, macromolecules and
charged organics. Emisphere and its partners have advanced oral
formulations or prototypes of salmon calcitonin, heparin, insulin,
parathyroid hormone, human growth hormone and cromolyn sodium into clinical
trials. Emisphere has strategic alliances with world-leading pharmaceutical
companies. For further information, please visit the Emisphere website,
http://www.emisphere.com.
    Safe Harbor Statement Regarding Forward-looking Statements
    The statements in this release and oral statements made by
representatives of Emisphere relating to matters that are not historical
facts (including without limitation those regarding the timing or potential
outcomes of research collaborations or clinical trials, any market that
might develop for any of Emisphere's product candidates and the sufficiency
of Emisphere's cash and other capital resources) are forward-looking
statements that involve risks and uncertainties, including, but not limited
to, the likelihood that future research will prove successful, the
likelihood that any product in the research pipeline will receive
regulatory approval in the United States or abroad, the ability of
Emisphere and/or its partners to develop, manufacture and commercialize
products using Emisphere's drug delivery technology, Emisphere's ability to
fund such efforts with or without partners, and other risks and
uncertainties detailed in Emisphere's filings with the Securities and
Exchange Commission, including those factors discussed under the caption
"Risk Factors" in Emisphere's Annual Report on Form 10-K (file no. 1-10615)
filed on March 5, 2007.

SOURCE Emisphere Technologies, Inc.

http://www.emisphere.com
CONTACT:
Stewart Siskind, Investor Relations, of
Emisphere Technologies, Inc., +1-914-785-4742; or media, Dan
Budwick of BMC Communications, +1-212- 477-9007, ext. 14, for
Emisphere Technologies, Inc.